Breaking News

You are here » Indian-Commodity  :  Commodities  :  Pepper Futures Trading Mixed On NCDEX

13-May2011

Pepper Futures Trading Mixed On NCDEX

Pepper commodity are exchanging combined, though the around month settlement has lengthy their drop on Friday on the earnings profit at the better levels, others are buying and selling in green. Though, investors expect a recover in costs on great move and local need, reduce securities and a drop in output.

The settlement for May supply was buying and selling at Rs 30429.00, lower by 0.45% or Rs 138.00 from their prior finishing of Rs 30567.00. The available interest of settlement were standing at 6563 lots.

The deal for June supply was exchanging at Rs 30330.00, upwards by 0.31% or Rs94.00 from their prior finishing of Rs 30236.00. The available interest of settlement were standing at 14252 lots on NCDEX.

Related News

View all news

BT Cotton Seeds Businesses Targeting Earnings Of Rs 700 Crore This Season

BT Cotton seeds organizations are targeting earnings of Rs 700 cr this season as a result of a rise ......

Gold Challenges To Maintain Earlier Increases As The Problems In Europe Prolongs

Gold prices surrounded reduce on Monday because the euro solved their deficits in opposition to the ......

Copper Seems To Lengthen Uptrend As Dollar Recoils

Copper rates were able to lengthen the uptrend for 3rd instantly period on Monday, as traders proved......

Top News

View all news

Aurobindo Pharma, TVS Motor and Lupin to see some action today

Aurobindo Pharma's wholly owned subsidiary -- Aurobindo Pharma USA Inc., has entered into an agreement to acquire a product under development and related assets from 'Advent Pharmaceuticals Pty, Australia,......

TVS Motor launches TVS Apache RTR 160 4V in Bangladesh

TVS Motor Company has launched the TVS Apache RTR 160 4V in Bangladesh. A testimony to the racing legacy of the TVS Apache RTR series, the TVS Apache RTR 160 4V will be the flagship offering of the brand......

Aurobindo Pharma's arm enters into agreement with Advent Pharma

Aurobindo Pharma's wholly owned subsidiary -- Aurobindo Pharma USA Inc. -- has entered into an agreement to acquire a product under development and related assets from Advent Pharmaceuticals Pty, Australia,......